Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall  by Snowball, John et al.
Mesenchymal Wnt signaling promotes formation of sternum
and thoracic body wall
John Snowball a, Manoj Ambalavanan a, Bridget Cornett a, Richard Lang b,c,
Jeffrey Whitsett a,c, Debora Sinner a,c,n
a The Perinatal Institute Division of Neonatology, Perinatal and Pulmonary Biology, Cincinnati, OH 4522, USA
b The Visual Systems Group Division of Developmental Biology and Ophthalmology, Cincinnati Children's Medical Center Research Foundation,
Cincinnati, OH 45229, USA
c University of Cincinnati, College of Medicine, Cincinnati, OH 45229, USA
a r t i c l e i n f o
Article history:
Received 3 November 2014
Received in revised form
17 February 2015
Accepted 18 February 2015







a b s t r a c t
Midline defects account for approximately 5% of congenital abnormalities observed at birth. However,
the molecular mechanisms underlying the formation of the ventral body wall are not well understood.
Recent studies linked mutations in Porcupine—an O-acetyl transferase mediating Wnt ligand acylation—
with defects in the thoracic body wall. We hypothesized that anomalous Wnt signaling is involved in the
pathogenesis of defective closure of the thoracic body wall. We generated a mouse model wherein
Wntless (Wls), which encodes a cargo receptor mediating secretion of Wnt ligands, was conditionally
deleted from the developing mesenchyme using Dermo1Cre mice. Wlsf/f;Dermo1Cre/þ embryos died
during mid-gestation. At E13.5, skeletal defects were observed in the forelimbs, jaw, and rib cage. At
E14.5, midline defects in the thoracic body wall began to emerge: the sternum failed to fuse and the
heart protruded through the body wall at the midline (ectopia cordis). To determine the molecular
mechanism underlying the phenotype observed in Wlsf/f;Dermo1Cre/þ embryos, we tested whether
Wnt/β-catenin signaling was operative in developing the embryonic ventral body wall using Axin2LacZ
and BatGal reporter mice. While Wnt/β-catenin signaling activity was observed at the midline of the
ventral body wall before sternal fusion, this pattern of activity was altered and scattered throughout the
body wall after mesenchymal deletion of Wls. Mesenchymal cell migration was disrupted in Wlsf/f;
Dermo1Cre/þ thoracic body wall partially due to anomalous β-catenin independent Wnt signaling as
determined by in vitro assays. Deletion of Lrp5 and Lrp6 receptors, which mediate Wnt/β-catenin
signaling in the mesenchyme, partially recapitulated the phenotype observed in the chest midline of
Wlsf/f;Dermo1Cre/þ embryos supporting a role for Wnt/β-catenin signaling activity in the normal
formation of the ventral body wall mesenchyme. We conclude that Wls-mediated secretion of Wnt
ligands from the developing ventral body wall mesenchyme plays a critical role in fusion of the sternum
and closure of the secondary body wall. Thus, impaired Wls activity in the ventral body wall
mesenchyme is a mechanism underlying ectopia cordis and unfused sternum.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Midline defects of the ventral body wall are observed in 1:2500
live births. The Pentalogy of Cantrell (PC) is a rare disorder (approx-
imate incidence of 1:65,000 live births) typiﬁed by a constellation of
congenital malformations affecting the heart, diaphragm, sternum,
abdominal wall, and pericardium (Cantrell et al., 1958). Even with
advances in surgical interventions, morbidity and mortality of this
disorder remain high (O’Gorman et al., 2009). The abnormalities
associated with PC vary considerably, but ectopia cordis, absent or cleft
sternum and abdominal wall defects are commonly observed anoma-
lies. While the anatomic ﬁndings of PC are well established, the
pathogenesis or genetic causes of PC are unknown. Recent studies
identiﬁed mutations in Porcupine (PORCN) in individuals with PC and
Focal Dermal Hypoplasia (also known as Goltz–Gorlin Syndrome)
(Smigiel et al., 2011) or with body-wall complex syndrome (Maas
et al., 2009).
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Porcupine is an O-acyltransferase involved in the acylation of
Wnt ligands; this post-translational modiﬁcation is required for
secretion and biological activity of most Wnt ligands (Coombs et al.,
2010; Komekado et al., 2007). Porcupine, located on the X chromo-
some, has been linked to Focal Dermal Hypoplasia (FDH), a condition
primarily affecting skin and in some cases, the abdominal wall (Wang
et al., 2007). Moreover, deletion of Porcupine (Porcn) in mice caused
FDH and abnormal development of the body wall (Barrott et al.,
2011). It is presently unclear whether PORCN mutations are also the
cause of PC. Mouse studies have demonstrated that deletion of
various components of the Wnt/β-catenin signaling pathway affects
formation of the sternum. Conditional deletion of either co-receptors
Lrp5 and Lrp6 or the Wnt nuclear transducer β-catenin in mesench-
ymal tissue causes a dysmorphic sternum that failed to fuse at the
midline (Joeng et al., 2011). Similarly, conditional deletion of GSK-3β,
a Wnt/β-catenin signaling modulator, causes midline defects includ-
ing biﬁd sternum and delayed sternal ossiﬁcation (Hoeﬂich et al.,
2000; Liu et al., 2007). Moreover, Wnt/β-catenin activity is detected
in developing dermis and sternum during normal development
(Chen et al., 2012; Ohtola et al., 2008). Taken together, these clinical
and experimental data support the concept that Wnt/β-catenin
signaling participates in formation of the ventral body wall.
Previous studies, including our own investigations, demonstrated
that Wntless (Wls) is a critical component of the Wnt signaling
pathway and is required for the morphogenesis of various organs
including lung and skin (Augustin et al., 2013; Carpenter et al., 2010;
Cornett et al., 2013; Fu and Hsu, 2013; Huang et al., 2012). As a cargo
receptor that mediates Wnt ligand secretion from producing cells,
Wls acts downstream of PORCN-mediated acylation of Wnt ligands
(Coombs et al., 2010; Herr and Basler, 2012). Given the ﬁnding that
Porcn is present in Wnt-producing cells of the midline dermis (Ohtola
et al., 2008) and that mutations in Porcn have been associated with
midline defects, we sought to test whether secretion of Wnt ligands,
mediated by Wls, affects ventral body wall formation.
In this study, we utilized Dermo1Cre mice (Yu et al., 2003) to
conditionally delete Wls in the embryonic mesenchyme-speciﬁ-
cally, the lateral plate mesoderm, somites and dermis of develop-
ing body wall (Li et al., 1995). Wls expression in the mesenchyme
of the ventral body wall is required for migration of mesenchymal
cells to the midline, closure of the secondary body wall and
formation of the sternum. Thus, we provide evidence supporting
the concept that anomalous production or activity of Wnt ligands
from the mesenchyme is involved in the pathogenesis of con-
genital midline malformations such as ectopia cordis and unfused
sternum.
Material and methods
Mouse breeding and genotyping
Animals were housed in pathogen-free conditions and
handled according to protocols approved by CCHMC Institu-
tional Animal Care and Use Committee (Cincinnati, OH, USA).
Generation of the Wntless (Wls) conditional knock-out (CKO)
mouse has been described. Wlsf/f;Dermo1Cre/þ embryos were
generated by breeding Wlsf/f mice with Dermo1Cre/þ mice (Sosic
et al., 2003) and recrossing resultant mice with Wlsf/f. Wlsf/f;
Dermo1Cre/þ;Axin2LacZ and Wlsf/f;Dermo1Cre/þ;BatGal mice were
obtained by mating Wlsf/þ Dermo1Cre/þ with Axin2LacZ (Joeng
et al., 2011; Lustig et al., 2002) or BatGal mice (Maretto et al.,
2003), respectively. Wlsf/f;Dermo1Cre/þ;Rosa mT/mG embryos
were generated by breeding Wlsf/þ;Dermo1Cre/þ with Rosa
mT/mG mice (Muzumdar et al., 2007). Wlsf/f;Col2a1Cre/þ were
generated by breeding Wlsf/f mice with Col2a1Cre/þ mice
(Ovchinnikov et al., 2000) and breeding resultant mice with
Wlsf/f. Lrp5/6f/f;Dermo1Cre/þ were obtained by crossing Lrp5f/f
Lrp6f/f mice (Joeng et al., 2011) with Dermo1Cre/þ and recrossing
the offspring to Lrp5f/f;Lrp6f/f mice. Sox9f/f;Dermo1Cre/þ mice
were obtained by breeding Sox9f/f(Kist et al., 2002) with Der-
mo1Cre/þ mice and mating resultant mice to Sox9f/f mice. Wlsf/f;
Dermo1Cre/þ;Sox9EGFP embryos were generated by breeding
Wlsf/f mice with Sox9EGFP mice (Gong et al., 2003) and breeding
resultant mice with Wlsf/þ;Dermo1Cre/þ . Genotypes of trans-
genic mice were determined by PCR with genomic DNA isolated
from mouse tail or embryonic tissue. Primers utilized for
genotyping have been provided as Supplementary material
(Table S1).
Histology, immunohistochemistry and immunoﬂuorescence staining
Embryonic tissue was ﬁxed and embedded in parafﬁn or frozen
using OCT. Sections (6 μm) were processed for H&E or DAB staining as
described (Mucenski et al., 2003). For immunoﬂuorescence, sections
were blocked with normal serum and incubated with a mix of primary
antibodies overnight at 4 1C. Fluorochrome-conjugated anti-IgG anti-
bodies were applied for one hour at room temperature, and sections
were preserved in VECTASHIELD mounting medium with DAPI
(Vector) to visualize nuclei. Primary antibodies included Sox9 (Milli-
pore), α Smooth Muscle Actin (αSMA, Sigma), antiBrdU, antiGFP and
phosphohistone-H3 (PHH3) (Santa Cruz).
In-situ hybridization
Procedure was performed according to a protocol developed by
Advanced Cell Diagnostics (ACD) (Wang et al., 2012). In situ probes
were designed by ACD. In brief, slides were baked and deparafﬁ-
nized. Each slide was then permeabilized and washed. In situ
probes were added to the slides and hybridization was performed
for 2 h at 40 1C followed by several rounds of ampliﬁcation steps.
Finally, chromogenic reaction using DAB and counter-staining
with Hematoxylin was performed on slides. After mounting with
permanent mounting media, slides were photographed using a
wide ﬁeld Nikon i90 microscope.
Whole mount X-galactosidase staining
Whole embryos were ﬁxed in 4% paraformaldehyde (PFA) in PBS
for 30 min, then washed in PBS and incubated for two to three
hours in X-gal staining solution. To stop the reaction, explants were
washed in 3% dimethyl sulfoxide-PBS, rinsed in PBS, and stored in
70% ethanol. Before imaging, explants were dehydrated in methanol
and cleared in methyl salicylate. Samples were then dehydrated in a
graded series of ethanol, and processed for parafﬁn embedding and
sectioning.
Cell proliferation and cell death
Sections from E11.5 embryos were labeled with PHH3 antibody
to identify mitotic cells in body wall and ﬂanks. Labeled cells and
total cells were counted per each ﬁeld photograph at 20 and
ratios of proliferating to total cell numbers were calculated.
Average mitotic index was determined for three different samples.
Cell proliferation was also determined by incorporation of BrdU.
Dams were injected with BrdU (1 mg/g body weight) at E11.5.
Embryos were harvested at E13.5 and processed for parafﬁn
embedding. Sections were stained with antiBrdU antibody and
Sox9 or αSMA antibody. Average mitotic index was determined as
previously described. Cell death was determined by TUNEL assay
performed on sections of E13.5 and E14.5 embryos using a
commercially available detection kit (Roche).
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MEF cell isolation and culture
Embryos were harvested at E13.5. Chest ﬂank regions of at least
three embryos of the same genotype (Wlsf/f or Wlsf/f;Dermo1Cre/þ)
were isolated, washed in PBS, minced in trypsin and incubated for
10 min at 37 C. After incubation, tissue was pipetted until cell
suspension formed. Cells were seeded in ﬂasks containing MEF
tissue culture media composed of DMEM, 1% penicillin/strepto-
mycin and 20% non-heat inactivated FBS.
Migration assay
MEF cells were seeded as monolayer in 24 well plates. Using a
200 μl pipet tip, a wound was induced in the monolayer. Culture
media were removed and replaced with media containing low
percentage of non-heat inactivated FBS and recombinant Wnt
ligands Wnt5a or Wnt3a (100 ng/ml) (R&D), Ca2þ/calmodulin-
dependent protein kinase inhibitor KN93 (10 μM) (Millipore), or
JNK inhibitor II (25 μM) (Millipore). Images were acquired at 0, 7,
11 and 24 h post-scratch using an Olympus inverted microscope.
Migration was determined as the ratio of covered surface to initial
wound surface using Image J (NIH) software.
RNA extraction and RT-PCR
Gene expression was determined by quantitative RT-PCR. RNA
was isolated from embryonic tissue using a commercially available
kit (RNAeasy minikit or microkit, Qiagen-Promega). Four body wall
samples were pooled for RNA extraction, while three ﬂank samples
were pooled for RNA extraction. Reverse transcription was per-
formed according to manufacturer instructions (Verso Fisher Sci),
and Taqman probes (Life Technologies) were utilized to detect
differential expression using a StepOnePlus RT-PCR System.
Statistics
Quantitative data were presented as mean plus standard error.
Experiments were repeated at least twice with a minimum of
three biological replicates for each group. Statistically signiﬁcant
differences were determined by paired T-test, one-way ANOVA
followed by Bonferroni's multiple comparisons test using Graph
Pad Prism. Signiﬁcance was set at po0.05.
Results
Deletion of Wls from embryonic mesenchymal progenitors causes
skeletal anomalies: To test whether secretion of Wnt ligands from
mesenchymal progenitors is required for the formation of the
ventral body wall, we conditionally deleted Wls using Dermo1Cre
mice. While morphological abnormalities were not observed at
E12.5, several congenital abnormalities were readily observed in
Wlsf/f;Dermo1Cre/þ embryos at E13.5. At this developmental stage,
no digits were detected in the forelimbs, and the jaw was under-
developed (micrognathia) (arrow Fig. 1A). At E14.5, mass and
crown-rump length were reduced in Wlsf/f;Dermo1Cre/þ embryos.
Embryos were hemorrhagic and had ectopia cordis (exposed heart)
along with malformed sternum, which failed to fuse in the midline
of the chest cavity (Fig. 1A and B, dotted line). The abnormal
thoraxes had decreased width, as seen in the coronal plane of
embryos (Fig. 1C). Conversely, the lungs, where Dermo1 (Twist2) is
broadly expressed, were only marginally affected by deletion of
Wls. While early cell differentiation was not perturbed (Cornett
et al., 2013), Wlsf/f;Dermo1Cre/þ lungs were elongated, presumably
as a secondary effect due to the abnormal chest cavity observed in
these embryos (Fig. 1B,C and Supplementary Fig. 1). No live
embryos were recovered after E14.5 indicating embryonic lethal-
ity. These data demonstrate that conditional deletion of Wls from
mesenchymal progenitors impaired formation of skeletal struc-
tures and the thoracic body wall.
To formally demonstrate the extent of the mesenchymal deletion
of Wls in ventral body wall, we analyzed the efﬁciency of recom-
bination of Dermo1Cre/þ using the reporter mouse Rosa mT/mG
(Tomato/GFP). As early as E9.5, we detected Cre-mediated recombi-
nation in cells expressing Dermo1, as indicated by expression of GFP
in somites and lateral plate mesoderm (Fig. 2A–C). In this model,
cells that failed to undergo Cre mediated recombination expressed
tdTomato ﬂuorescent protein (Muzumdar et al., 2007). As develop-
ment progressed, GFP was detected in ventral body wall dermis—
derivative of mesenchymal progenitors—but was excluded from
the cardiac atrium and ventricle tissue (Fig. 2D). Similar levels and
speciﬁcity of recombination were observed in both control and
Wlsf/f;Dermo1Cre/þ;Rosa mT/mG embryos, as indicated by GFP expres-
sion (Fig. 2D–F). Dermo1Cre mediated recombination was observed
in both Sox9 and αSMA (smooth muscle actin) expressing cells
present in the ventral body wall of Wlsf/f;Dermo1Cre/þ;Rosa mT/mG
embryos (Fig. 2G, H). Hence, deletion ofWls using Dermo1Cremice is
a useful model to study the Wls-mediated signaling from mesench-
ymal cells of the ventral body wall.
Wnt/β-catenin signaling is operative before sternal fusion: Since
Wls mediates secretion of Wnt ligands from producing cells, we
reasoned that the lack of fusion of the sternum inWlsf/f;Dermo1Cre/þ
mice was the result of impairedWnt signaling activity in the ventral
body wall. To test whether Wnt/β-catenin signaling was active in
the developing dermis of the ventral body wall, we crossed
Axin2LacZ and Batgal reporter mice with Wlsf/f;Dermo1Cre/þ mice
(Fig. 3A and B). At E13.5, we detected Lac-Z staining in the ventral
body wall of control embryos that converged at the midline as a
deﬁnitive stripe. In contrast, in the Wlsf/f;Dermo1Cre/þ;Axin2LacZ or
Wlsf/f;Dermo1Cre/þ;BatGal mice, Lac-Z staining was scattered
throughout the ventral body wall and well-deﬁned midline staining
was not detected. The staining in ventral body walls of Wlsf/f;
Dermo1Cre/þ was more intense than in ventral body wall of control
embryos. Analysis of cross sections determined that in Wlsf/f;
Dermo1Cre/þembryos, Lac-Z staining was present in mesenchymal
cells and to a lesser extent in the epidermal layer of developing
secondary body wall (Fig. 3B). These data support the concept that
Wnt/β-catenin signaling is active in the mesenchyme of the devel-
oping ventral body wall of both control and Wlsf/f;Dermo1Cre/þ
embryos and that mesenchymal deletion of Wls does not comple-
tely abrogate the capability of body wall mesenchymal cells to
respond to Wnt/β-catenin signaling.
Wnt ligands are expressed in ventral wall dermis: Since Wnt/β-
catenin signaling is active in the ventral body wall dermis, we
sought to identify which Wnt ligands were expressed in the
anterior body wall using a candidate approach. At E11.5 and
E13.5, Wnt2, Wnt2b, Wnt5a, Wnt7b and Wnt11 mRNA were
detected in ventral body wall tissue by qRT-PCR (Fig. 3C). To
determine the precise spatial expression pattern we performed
in situ hybridization. At E13.5, Wnt2 and Wnt2b mRNAs were
detected in the mesenchyme of the ventral body wall. Wnt2
transcripts were also detected in the epithelium of the body wall.
Wnt7b was primarily detected in the epithelium (ectoderm) of the
body wall and to a lesser extent was detected in the body wall
mesenchyme. Wnt5a and Wnt11, which are known to mediate
Wnt/β-catenin independent signaling, were detected at high levels
in the mesenchymal cells of the body wall; Wnt5a expression was
not prominent in the epidermis of the body wall (Fig. 3D). qRT-PCR
and in situ hybridization assays revealed no signiﬁcant differences
in Wnt ligand mRNA levels in the midline tissues of E11.5 control
andWlsf/f;Dermo1Cre/þ embryos (Supplementary Fig. 2). Fzd recep-
tors, Fzd1, 4, 7, and 10, which are necessary for transduction of
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Wnt signals, were expressed in the ﬂanks and midline of the body
wall (Supplementary Fig. 2). Wls mRNA was present in epithelium
(ectoderm), muscle, cartilage, and mesenchyme of the secondary
body wall of control embryos (Fig. 3D). Taken together, these
data support the concept that cells of the ventral body wall are
capable of producing and responding to β-catenin dependent and
β-catenin independent Wnt signaling. Wnt ligands that typically
elicit a β-catenin independent response were expressed primarily
in the mesenchyme of the body wall while Wnt ligands eliciting
Wnt/β-catenin signaling are expressed in the epithelial cells
(ectoderm) of the body wall. These data also support the concept
that transcription of Wnt ligands was not affected by mesenchy-
mal deletion of Wls.
Faulty closure of the thoracic body wall in Wlsf/f;Dermo1Cre/þ
embryos is associated with decreased apoptosis at the midline: To test
whether the lack of fusion of the sternal bars in theWlsf/f;Dermo1Cre/þ
embryo was related to diminished cell proliferation, mitotic index was
determined by incorporation of BrdU in cells of the body wall. Dams
were injected with BrdU at E11.5 and sacriﬁced at E13.5 when
incorporation of the synthetic nucleoside was analyzed in developing
body wall. Cell proliferation was not altered in Sox9 stained cells
(which labels chondroblasts) or in αSMA stained cells (Supplementary
Figs. 3 and 4). Previous studies have shown that anomalous formation
of the secondary body wall was associated with increased cell death
(Brewer and Williams, 2004; Ohtola et al., 2008). At E13.5, a low
percentage of apoptotic cells (less than 2%) was identiﬁed in control
Fig. 1. Congenital malformations afterWls deletion from mesenchymal progenitors. Deletion of Wls in embryonic mesenchyme causes craniofacial (white arrow, A), skeletal
(white arrowhead,A) and midline defects (C). Weight and crown-rump length are diminished in Wlsf/f;Dermo1Cre/þ embryos (A). Malformed sternum and exposed heart
(ectopia cordis) are reminiscent of Pentalogy of Cantrell (B). Extent of the lack of fusion of the sternum (dotted line, C) as determined by GFP ﬂuorescence in the Wlsf/f;
Dermo1Cre/þ;Sox9EGFP mouse at E14.5 (C). H&E staining depicts the anomalous shape of the rib cage after mesenchymal deletion of Wls in E13.5 embryos (D). The widest
region of the rib cage is diminished in Wlsf/f;Dermo1Cre/þ embryos (D). Lu¼Lung, L¼Limb, N¼4 nnnpo0.001.
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and Wlsf/f;Dermo1Cre/þembryos by TUNEL assay and no signiﬁcant
differences in apoptosis were observed (data not shown). Interestingly,
we detected apoptotic cells located between the converging sternal
bars of E14.5 control embryos (Fig. 4A, arrow head). These cells localize
in the same region where αSMA stained cells are found at the midline
of control ventral body wall (Fig. 4B). In contrast, no apoptotic cells
were detected in body wall midline of E14.5 Wlsf/f;Dermo1Cre/þ
embryos since the sternal bars failed to converge; however, a few
number of apoptotic cells were detected in the ﬂanks of E14.5 Wlsf/f;
Dermo1Cre/þ embryos. Taken together, mesenchymal deletion of Wls
did not impair the proliferative capability of cells within the body wall;
however, Wls was required for the induction of apoptosis of cells
located between sternal bars at E14.5 that were not detected in body
wall of Wlsf/f;Dermo1Cre/þembryos.
Cell migration towards the midline is impaired after deletion of
Wls from mesenchyme: The lack of midline fusion of the sternal bars
in Wlsf/f;Dermo1Cre/þ embryos at the midline was not the product of
altered cell proliferation or speciﬁcation. Accordingly, this failure of
midline fusion suggests that in the absence of mesenchymal Wnt
ligand secretion, cells within the mesenchyme of the body wall do
not migrate properly (Fig. 4C). Therefore, we analyzed in vitro the
migratory capacity of mesenchymal cells isolated from the E13.5
embryonic ﬂanks. Flank cells of both control and Wlsf/f;Dermo1Cre/þ
embryos were able to migrate to produce wound closure. Cells
isolated from ﬂanks of Wlsf/f;Dermo1Cre/þ embryos migrated slower
than control cells. To test the hypothesis that Wnt ligands secreted by
mesenchymal cells mediate cell migration, we performed wound-
healing assays in the presence of Wnt ligands Wnt3a and Wnt5a,
ligands known to induceWnt/β-catenin dependent and independent
responses respectively. While Wnt3a did not affect the migratory
ability of the cells isolated from control or Wlsf/f;Dermo1Cre/þ ﬂanks,
addition of Wnt5a partially improved cell migration of Wlsf/f;Der-
mo1Cre/þ cells (Fig. 5A). Since Wnt5a andWnt11 are highly expressed
in the mesenchyme of the ventral body wall and these ligands are
known to activate Wnt signaling independently of β-catenin, we
tested whether inhibition of the “Caþ þ” or “PCP” Wnt pathways,
impaired migration of mesenchymal cells. The calcium inhibitor
KN93 impaired cell migration (Sumi et al., 1991), while addition of
JNK inhibitor II, (Han et al., 2001), strongly impaired cell migration
(Fig. 5B). Taken together, these data support the concept that Wnt
ligand secretion from the body wall mesenchyme is required for cell
migration. In vitro, β-catenin independent Wnt signaling mediates
migration of mesenchymal cells isolated from the ﬂanks of control
and Wlsf/f;Dermo1Cre/þ embryos.
Midline mesenchymal cells in the ventral body wall are required
for fusion of the sternum: Dermo1Cre mediated recombination was
observed throughout the body wall mesenchyme in myoblasts,
connective tissue and chondrocytes of developing ribs and ster-
num. Therefore, we sought to identify Wnt-producing cells in
the body wall mesenchyme that are required for fusion of the
sternum. We assessed expression of Sox9 in differentiating chon-
drocytes to test whether lack of Wls-mediated signaling affects their
differentiation. Sox9 staining was similar in Wlsf/f;Dermo1Cre/þ and
control embryos (Fig. 4C , Supplementary Figs. 3 and 4). We deleted
Wls from chondrocytes using Col2a1Cre mice and detected defects in
digits of fore and hindlimbs at E15.5 (Fig. 6A and B). Deletion of Wls
from chondrocytes did not affect closure of the thoracic body wall
(Fig. 6C and D). Moreover, E18.5 Wlsf/f;Col2a1Cre/þ embryos were
recovered at expected Mendelian ratios without midline defects
(Fig. 6 E and F). Efﬁciency and speciﬁcity of recombination was
Fig. 2. Efﬁciency and distribution of Dermo1Cre-mediated mesenchymal recombination. Whole mount images (A–D) and longitudinal sections (E, F) of Wlsf/f;Dermo1Cre/þ;
Rosa mT/mG embryos are shown. Dermo1Cre-mediated recombination is detected in the mesenchyme as early as E9.5 and progressively expands throughout the
mesenchyme as development progresses (A–D). At E12.5, Dermo1Cre-mediated recombination in the body wall is extensive, as demonstrated by the GFP signal in both
control and Wlsf/f;Dermo1Cre/þ embryos (E, F). Cre recombination, detected using GFP, was present in both aSMA (white arrows) and Sox9 (white arrowhead) stained cells of
the ventral body wall (G,H and H' inset).
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conﬁrmed by PCR and by mating the Wlsf/f;Col2a1Cre/þ mice to the
reporter mice Rosa mT/mG (data not shown). We also deleted Sox9
using Dermo1Cre to target chondrocytes progenitors in the body
wall. While several skeletal defects including short limbs, and
smaller rib cage were observed in Sox9f/f;Dermo1Cre/þ embryos
(Fig. 6G and H), the ventral body wall closed normally (Fig. 6 arrow
in J and arrow head in L). Analysis of αSMA staining of skeletal and
smooth muscle was similar in control and Wlsf/f;Dermo1Cre/þ
embryos (Fig. 4A and B, Supplementary Fig. 3). These data support
the concept that differentiation of chondrocytes and smooth muscle
ﬁbroblasts was maintained after deletion ofWls from mesenchymal
body wall precursors. These data also suggest that Wnt ligands
Fig. 3. Wnt/β-catenin signaling is operative in ventral body wall. Canonical Wnt signaling was assessed in E13.5 Wlsf/f;Dermo1Cre/þ embryos. In control embryos, LacZ staining
was detected in the ventral body wall converging at the midline as a well-deﬁned stripe (arrowheads in A and B control). In the Wls Wlsf/f;Dermo1Cre/þ;Axin2LacZ (A) and Wlsf/f;
Dermo1Cre/þ;BatGal embryos (B), staining was scattered throughout the ventral body wall, and deﬁnitive midline staining was not detected (arrowhead in A and B Wlsf/f;
Dermo1Cre/þ panels). Cross sections of the whole mounts show the extent of Wnt/β-catenin signaling in the ventral body wall of control andWlsf/f;Dermo1Cre/þ;BatGal embryos,
(B). White dotted lines indicate the plane of section (B). Levels of Wnt ligandmRNA in body wall tissue were determined at E11.5 and E13.5 by RT-PCR (C). Cross sections of E13.5
embryos were hybridized with riboprobes to detect mRNA for Wnt ligands Wnt2, Wnt2a Wnt7b, Wnt5a and Wnt11, as well as Wls transcripts. Low magniﬁcation and high
magniﬁcation of the areas in squares are shown for each staining. Wls mRNA was detected in both epithelium and mesenchyme, including developing ribs and muscle of the
thoracic body wall (D). Li¼ limb, n¼heart.
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produced by chondrocyte progenitors are either not essential to or
play a redundant role in the formation and closure of the thoracic
body wall.
Wnt ligands known to induce Wnt/β-catenin signaling are required
for body wall formation: To test the role of Wnt ligands that mediate
Wnt/β-catenin activity in ventral body wall formation, we used
Dermo1Cre mice to deleted co-receptors Lrp5 and Lrp6 which
mediate Wnt/β-catenin signaling. In agreement with previous
studies (Joeng et al., 2011) and with present observations in Wlsf/f;
Dermo1Cre/þ embryos, the chest wall was abnormal and the heart
was exposed in association with failure of sternal fusion (Fig. 7A,
arrow). In contrast to ﬁndings in Wlsf/f;Dermo1Cre/þ embryos,
mesenchymal deletion of Lrp5 and Lrp6 prevented the closure of
the abdominal wall exposing the liver outside of the abdomen
(Fig. 7A arrowhead). In comparison to the abnormalities observed in
Wlsf/f;Dermo1Cre/þ embryos (Fig. 1), chest cavity shape in Lrp5/6f/f;
Dermo1Cre/þ embryos was unaltered (Fig. 7B) and lung morphology
was normal (Fig. 7B). Similar indices of cell proliferation were
detected in the ﬂanks of control and Lrp5/6f/f;Dermo1Cre/þ embryos,
at E11.5 (Supplementary Fig. 4). Speciﬁcation of chondroblasts
and myoblasts occurred properly (Fig. 7C and Supplementary
Fig. 4). At E14.5, the width of the ventral body wall was reduced
Fig. 4. Decreased apoptosis in ventral body wall and impaired migration to midline after mesenchymal loss of Wls. TUNEL staining was performed on cross and longitudinal
sections of E14.5 control and Wlsf/f;Dermo1Cre/þ embryos (A). Note the cell death at the midline (corresponding to the region between the fusing sternal bars) in the control
body wall (arrow). This pattern is absent in mutants. Representative images and higher magniﬁcations of areas in square are shown. The midline region where apoptosis
takes place in control embryos (A) overlaps with a region that stains positive for αSMA (B). Cross sections of E14.5 embryos stained with Sox9 and αSMA antibodies
demonstrate the extent of the lack of fusion of sternal bars in mutants (dotted line) and the position of αSMA stained cells between the sternal bars in control embryos (C).
H¼heart.
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in both Lrp5/6f/f;Dermo1Cre/þ and Wlsf/f;Dermo1Cre/þ embryos; how-
ever, in Lrp5/6f/f;Dermo1Cre/þ a reduction of the body wall width was
detected as early as E11.5. At E14.5, the mesenchyme of the ventral
body wall was almost absent, making it difﬁcult to differentiate the
body wall from the cardiac tissue (Fig. 7C, D and Supplementary
Fig. 4). Deletion of Lrp5 and Lrp6 did not cause signiﬁcant changes in
levels ofWntmRNAs, as determined by in situ hybridization and qRT-
PCR (Supplementary Fig. 5). Taken together, these data support the
concept that deletion of Lrp5 and Lrp6 impaired differentiation of
mesenchymal dermal cells of the primary body wall and cell migration
of myoblasts and chondroblats towards body wall midline.
Discussion
In this study, we sought to identify the molecular mechanisms
underlying midline defects of the body wall and their relationship
to the congenital anomalies associated with the Pentalogy of
Cantrell. Failure of sternal fusion and resulting ectopia cordis, two
features of the Pentalogy of Cantrell, were caused by deletion of
Wls in mesenchymal precursors of the embryonic body wall. Wnt/
β-catenin activity, as determined by reporters Axin2LacZ and Batgal,
was observed in the thoracic body wall and was restricted to the
midline of the ventral body wall of control embryos during normal
development of the sternum. Wnt/β-catenin activity was dis-
persed in the thoracic body wall after deletion of Wls from
mesenchymal precursors. While speciﬁcation of cell types present
in the thoracic body wall was not affected by deletion of Wls from
mesenchymal precursors, cell migration to the midline was
disrupted. Addition of Wnt5a in vitro partially restored migration
of in mesenchymal cells lacking Wls, likely via Wnt/β-catenin
independent signaling. Thus,Wls promotes migration of myoblasts
and chondroblasts towards the midline to form the thoracic body
wall, at least in part by activating Wnt/β-catenin independent
signaling.
Which cells within the ventral mesoderm produce the Wnt ligands?
Several cell types are present in the developing body wall, including
chondrocytes, muscle cells and connective tissue cells, the latter
forming tendons and ligaments. In the present study deletion of
Wls from chondroblasts using a Col2a1Cre driver did not alter the
formation of the sternum. Likewise, mesenchymal deletion of Sox9, a
key regulator of chondroblast and osteoblast differentiation, did not
alter ventral body wall formation. Therefore, Wls-mediated secretion
of Wnt ligands by chondroblast precursors in the ventral body wall is
not required for closure of the body wall. Present ﬁndings support
the concept that mesenchynal cells that are precursors of muscle and
connective tissue likely produce the Wnt ligands necessary for body
wall formation. Furthermore, we observed that myoblasts seem to be
the leading cells migrating into the midline of the chest wall and are
present between the sternal bars before sternal fusion.
Mesenchymal Wls controls cell migration and cell survival in the
thoracic body wall midline: Formation of the primary body wall
depends upon multiple processes including cell migration, prolifera-
tion and differentiation (Sadler, 2010). Present studies demonstrate
that migration of chondroblasts and myoblasts towards the midline of
the thoracic body wall was abnormal after deletion of Wls from
mesenchymal precursors. Our in vitro studies demonstrated that cells
isolated from the ﬂanks of Wlsf/f;Dermo1Cre/þ embryos have impaired
migratory capability that can be partially rescued by exogenous
addition of Wnt5a. Thus, Wnt signaling from mesenchymal cells plays
Fig. 5. Wnt/β-catenin independent signaling is required for migration of mesenchymal ﬂank cells in vitro. Wound healing assays were performed on control and
WlsDermo1Cre cells isolated from the ventral ﬂanks of the thoracic cavity. Mesenchymal cells from WlsDermo1Cre embryos migrate slower than cells isolated from control
ﬂanks. Addition of Wnt5a partially improved the migratory ability of the WlsDermo1Cre cells (A). Inhibition of the PCP Wnt signaling pathway, using JNK inhibitor II,
impaired the migratory ability of control mesenchymal cells, while inhibition of calcium Wnt signaling using KN93, had a lesser effect on cell migration (B). Representative
images at initiation of the assay and 11 h post-wound are shown per each treatment. N¼6 ANOVA Bonferroni's multiple comparisons test; npo0.05 vs control, nnpo0.01 vs
control, and nnnpo0.001 vs control.
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Fig. 7. Conditional deletion of Lrp5 and Lrp6 caused midline defects. Deletion of genes encoding Lrp5 and Lrp6 from mesenchyme causes craniofacial anomalies and defects
in the ventral body wall (white arrow, A), partially resembling the phenotype seen after deletion of Wls in mesenchyme. Midline defects extend to the abdominal body wall,
where failure of midline closure leaves the liver exposed (white arrowhead, A). In contrast to ﬁndings in the Wlsf/f;Dermo1Cre/þ embryos, no anomalies in lung
morphogenesis were observed in Lrp5/6f/f; Dermo1Cre/þ embryos (B). Cross sections of E14.5 Wlsf/f;Dermo1Cre/þand Lrp5/6f/f; Dermo1Cre/þ embryos were stained with Sox9
and αSMA antibodies (C). Chondrocytes and myocytes were present in the ﬂanks and ventral body wall of control embryos. Myocytes appear as leading cells between the
almost fused sternal bars in controls (arrowheads in control, C); however, only poorly organized αSMA positive cells are present inWlsf/f;Dermo1Cre/þ and LRP5/6 Dermo1Cre
ventral body wall (C). Dotted white lines indicate width of the body wall, which is difﬁcult to distinguish from the cardiac tissue in Lrp5/6f/f; Dermo1Cre/þ embryos (C). Body
wall width was extremely reduced in Lrp5/6f/f; Dermo1Cre/þ embryos when compared to control and Wlsf/f;Dermo1Cre/þembryos (D). N¼3 to 6 nnpo0.01 vs control.
Fig. 6. Wls activity in chondroblasts is not necessary for midline closure. E15.5 Wlsf/f;Col2a1Cre/þ embryos did not display gross morphological anomalies compared to
control (A–F), except for abnormal digits observed in forelimbs and hindlimbs (insets A, B). Deletion ofWls in chondroblasts did not impair body wall closure or formation of
the sternum (C, D). E18.5Wlsf/f;Col2a1Cre/þ embryos in ventral view show no gross abnormalities in the ventral body wall (E,F). At E16.5, Sox9f/f;Dermo1Cre/þ embryos exhibit
several skeletal defects including shorter limbs and decreased crown-rump length (G, H). No defects in body wall closure were detected in Sox9f/f;Dermo1Cre/þ embryos at
E16.5 (I, J arrows) or at E18.5 (K, L arrowheads).
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a critical role in the fusion of the sternal bars and the closure of the
thoracic body wall.
Previous studies support the role of defects in cell proliferation
and/or increased cell death in anomalous body wall formation
(Brewer and Williams, 2004). In the present study cell prolifera-
tion was unaltered in Wlsf/f;Dermo1Cre/þ mutant embryos. Apop-
totic cells were present between the fusing sternal bars of control
mice at E14.5 creating a pattern resembling the apoptotic process
in leading cells during the normal fusion of palatal shelves (Cuervo
et al., 2002). This apoptotic pattern was not present in the thoracic
body wall of the Wlsf/f;Dermo1Cre/þ embryos. Decreased apoptosis
at the thoracic body wall midline after deletion of Wls was
associated with the abnormal migration of mesenchymal cells
from the ﬂanks of the body wall to the midline.
Cell differentiation is another critical aspect of body wall
formation. Multiple mesenchymal cell types, including chondro-
blasts and α–SMA stained myoﬁbroblasts were present in the
primary body wall of control and Wlsf/f;Dermo1Cre/þ embryos even
before formation of the secondary body wall. These ﬁndings
support the concept that differentiation of these cell types does
not depend on Wnt ligands produced by mesenchymal ﬁbroblasts.
Other tissues, such as the ectoderm, where Wnt2 and Wnt7b are
expressed, may provide the Wnt signals required for mesenchymal
cell differentiation. Wls is expressed in both ectodermal and
mesenchymal tissues of the body wall. Deletion of Wls from
ectodermal cells does not affect the thoracic body wall, but does
impair formation of the abdominal body wall muscle (Zhang et al.,
2014). While midline defects were readily observed in the Wlsf/f;
Dermo1Cre/þ model, we did not detect severe abnormalities in the
abdominal wall. Thoracic body wall and the abdominal body wall
have different developmental origins, i.e. thoracic somites vs
abdominal somites (Liem and Aoyama, 2009), then Wnt signaling
may play distinct roles in the formation of these two regions of the
body wall.
Wls modulates Wnt/β-catenin signaling activity during body wall
formation: There is a strong consensus that Wls plays an important
role in Wnt signaling by escorting Wnt ligands to the cell surface of
producing cells (Banziger et al., 2006; Hausmann et al., 2007). It
remains unclear whether Wls balances the activity of the β-catenin
dependent or independent branches of the Wnt signaling pathway by
differentially favoring the secretion of speciﬁc Wnt ligands. Present
data demonstrated that deletion of Wls in mesenchymal tissue
partially resembles the lack of sternal fusion observed after deletion
of co-receptors Lrp5, Lrp6 and β-catenin from developing embryonic
mesenchyme (Joeng et al., 2011), supporting the concept that devel-
opment of the sternum relies upon Wnt/β-catenin signaling. Studies
by Bryja and colleagues demonstrated that deletion of Lrp5 and Lrp6
promotes Wnt/β-catenin independent signaling induced by increase
of Wnt5a activity without changes in Wnt5a expression (Bryja et al.,
2009). We did not detect increased expression of Wnt5a or Wnt11 in
thoracic body wall of Lrp5/6f/f; Dermo1Cre/þ embryos; however, it is
possible that a shift in the molecular ratio of Wnt5a/Wnt11 to Lrp5/6
molecules resulted in ectopic Wnt/β-catenin independent signaling.
This excess in Wnt/β-catenin independent signaling may account,
at least partially, for the aberrant body wall phenotype observed in
Lrp5/6f/f; Dermo1Cre/þ embryos. Ectopic expression of Wnt5a in
embryonic tissue did not cause same midline defects as seen after
mesenchymal deletion of Lrp5 and Lrp6, but led to mild lower
sternum malformations (biﬁd sternum) while the secondary thoracic
body wall closed normally (van Amerongen et al., 2012). Present
studies demonstrated the requirement of Lrp5/Lrp6 (Fig. 7) and Wnt/
β-catenin independent signaling (Fig. 5) during formation of the
thoracic body wall. Bryja and colleagues demonstrated that interac-
tions between Lrp5/Lrp6 and Wnt ligands inducing Wnt/β-catenin
independent signaling are physiologically important and necessary
for normal development (Bryja et al., 2009). Therefore, it is likely that
balanced levels of Lrp5/Lrp6 (required for Wnt/β-catenin signaling)
and Wnt5/Wnt11 (ligands eliciting Wnt/β-catenin independent sig-
naling) may inﬂuence migration of cells towards the midline of the
body wall; deviations to this balance will result in faulty migration
and midline defects. Further analyses are required to formally
demonstrate this hypothesis.
Mesenchymal deletion of Lrp5 and Lrp6 caused a sharp reduc-
tion in the amount of mesenchymal tissue of the primary body
wall, a feature that was not as extensive as in the primary body
wall of Wlsf/f;Dermo1Cre/þ embryos. Lrp5 and Lrp6 are required for
reception of Wnt ligands, regardless of it source, to promote
Wnt/β-catenin signaling; it is likely that ectodermal ligands such
as Wnt2 and Wnt7b, and to lesser extent mesenchymal Wnt2 and
Wnt2b, may signal to the mesoderm to promote differentiation
and growth of dermal progenitors of the primary body wall that in
turn inﬂuence migration of myoblast and chondroblast to the
midline. This potential role for Wnt ligands produced by the
ectoderm is supported by studies demonstrating that ectodermal
Wls is required for differentiation of the abdominal wall muscle
(Zhang et al., 2014).
Fig. 8. Model for thoracic body wall formation. Wls activity in the developing mesenchyme of the body wall is required for normal formation of the sternum and secondary
body wall. Wnt ligands produced by mesenchymal myoﬁbroblasts promote migration of myoblasts and chondroblasts to the midline of the thoracic body wall via JNK and
Caþ þ Wnt signaling. Wnt2, Wnt2b and Wnt7b primarily from the ectoderm, via LRP5/6 and Wnt/β-catenin signaling, are necessary for differentiation and growth of the
ventral body wall mesenchyme where myoblasts and chondrocytes migrate to the midline.
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InWlsf/f;Dermo1Cre/þ embryos, Wnt/β-catenin signaling—as deter-
mined by the reporter mice Axin2LacZ and Batgal—was not abrogated
by mesenchymal deletion of Wls; however, the distribution of Wnt
signaling was detected as a scattered pattern throughout the thoracic
body wall without a deﬁned signal at the midline. A plausible ex-
planation for the anomalous pattern of Wnt/β-catenin activity in the
thoracic body wall is that deletion of Wls from mesenchymal
progenitors inﬂuenced the ability of cells to respond to Wnt ligands
Wnt2 and Wnt7b, produced by the ectoderm. It should be also
considered that mesenchymal Wnt5a and Wnt11, known to induce
β-catenin independent signaling, might play a role in modulating
Wnt/β-catenin signaling during ventral body wall formation, thus
balancing Wnt signaling pathway activities. Studies on developing
limb and hair follicle have shown that Wnt5a antagonizes Wnt/β-
catenin signaling to promote differentiation of these structures (Topol
et al., 2003; van Amerongen et al., 2012).
Conclusions
Wls activity in mesenchymal progenitors of connective and
muscle tissue of the embryonic body wall is required for formation
of the thoracic body wall. The model presented in this study
supports the concept that Wnt mediated migration of cells
towards the midline is critical for formation of the thoracic body
wall. Midline migration is controlled by secretion of Wnt ligands
from mesenchymal cells of the thoracic body wall. Ectodermal and
to lesser degree mesenchymal Wnt ligands promote Wnt/β-
catenin activity required for differentiation and growth of ﬁbro-
blasts of the primary body wall wherein myoblasts and chondro-
blasts migrate. Migration of myoblasts, connective tissue
precursors and chondroblasts towards the midline is partially
mediated via Wnt/β-catenin independent signaling. During the
closure of thoracic body wall, myoﬁbroblast migration precedes
migration of chondroblasts towards the midline (Fig. 8). Thus,
impaired activity of Wls in mesenchymal precursors of the body
wall may underlie the pathogenesis of unfused sternum and
ectopia cordis, both of which are characteristic of the midline
condition Pentalogy of Cantrell.
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